Journal article
Leptin receptor signaling in the hypothalamus regulates hepatic autonomic nerve activity via phosphatidylinositol 3-kinase and AMP-activated protein kinase
The Journal of neuroscience, Vol.35(2), pp.474-484
01/14/2015
DOI: 10.1523/JNEUROSCI.1828-14.2015
PMCID: PMC4293404
PMID: 25589743
Abstract
Leptin action in the brain has emerged as an important regulator of liver function independently from its effects on food intake and body weight. The autonomic nervous system plays a key role in the regulation of physiological processes by leptin. Here, we used direct recording of nerve activity from sympathetic or vagal nerves subserving the liver to investigate how brain action of leptin controls hepatic autonomic nerve activity. Intracerebroventricular (ICV) administration of leptin activated hepatic sympathetic traffic in rats and mice in dose- and receptor-dependent manners. The hepatic sympatho-excitatory effects of leptin were also observed when leptin was microinjected directly into the arcuate nucleus (ARC), but not into the ventromedial hypothalamus (VMH). Moreover, using pharmacological and genetic approaches, we show that leptin-induced increase in hepatic sympathetic outflow depends on PI3K but not AMP-activated protein kinase (AMPK), STAT3, or ERK1/2. Interestingly, ICV leptin also increased hepatic vagal nerve activity in rats. We show that this response is reproduced by intra-ARC, but not intra-VMH, leptin administration and requires PI3K and AMPK. We conclude that central leptin signaling conveys the information to the liver through the sympathetic and parasympathetic branches of the autonomic nervous system. Our data also provide important insight into the molecular events underlying leptin's control of hepatic autonomic nerve activity by implicating PI3K and AMPK pathways.
Details
- Title: Subtitle
- Leptin receptor signaling in the hypothalamus regulates hepatic autonomic nerve activity via phosphatidylinositol 3-kinase and AMP-activated protein kinase
- Creators
- Mamoru Tanida - Department of Physiology II, Kanazawa Medical University, Uchinada, Ishikawa 920-0293, Japan, Department of Internal Medicine, and mtanida@kanazawa-med.ac.jp kamal-rahmouni@uiowa.eduNaoki Yamamoto - College of Pharmacology, Hokuriku University, Kanazawa, Ishikawa 920-1180, Japan, andDonald A Morgan - Department of PharmacologyYasutaka Kurata - Department of Physiology II, Kanazawa Medical University, Uchinada, Ishikawa 920-0293, JapanToshishige Shibamoto - Department of Physiology II, Kanazawa Medical University, Uchinada, Ishikawa 920-0293, JapanKamal Rahmouni - Department of Pharmacology, Department of Internal Medicine, and Fraternal Order of Eagles Diabetes Research Center, University of Iowa Carver College of Medicine, Iowa City, Iowa 52242 mtanida@kanazawa-med.ac.jp kamal-rahmouni@uiowa.edu
- Resource Type
- Journal article
- Publication Details
- The Journal of neuroscience, Vol.35(2), pp.474-484
- Publisher
- United States
- DOI
- 10.1523/JNEUROSCI.1828-14.2015
- PMID
- 25589743
- PMCID
- PMC4293404
- ISSN
- 0270-6474
- eISSN
- 1529-2401
- Grant note
- HL084207 / NHLBI NIH HHS P01 HL084207 / NHLBI NIH HHS
- Language
- English
- Date published
- 01/14/2015
- Academic Unit
- Iowa Neuroscience Institute; Neuroscience and Pharmacology; Internal Medicine
- Record Identifier
- 9984040236102771
Metrics
11 Record Views